The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Dunne Michael W. since 2018.
This trader's CIK number is 1553593.
At the time of last reporting, Dunne Michael W. was the Officer of Iterum Therapeutics Plc. (stock ticker symbol ITRM).
Also see all insider trading activities at Iterum Therapeutics Plc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ITRM | 15,000 | $10,860 | 0 | $0 | 0 | $0 |
| 2024 | ITRM | 0 | $0 | 0 | $0 | 106,247 | $0 |
| 2023 | ITRM | 55,000 | $94,140 | 0 | $0 | 23,179 | $0 |
| 2022 | ITRM | 0 | $0 | 0 | $0 | 47,292 | $0 |
| 2021 | ITRM | 0 | $0 | 33,143 | $57,337 | 0 | $0 |
| 2020 | ITRM | 61,540 | $0 | 0 | $0 | 0 | $0 |
| 2018 | ITRM | 3,500 | $41,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-08 | ITRM | Buy | 15,000 | .72 | 10,860 |
| 2024-08-06 | ITRM | Option Ex | 106,247 | .00 | 0 |
| 2023-12-22 | ITRM | Buy | 25,000 | 1.40 | 35,000 |
| 2023-12-18 | ITRM | Buy | 10,000 | 1.84 | 18,440 |
| 2023-11-22 | ITRM | Buy | 20,000 | 2.04 | 40,700 |
| 2023-10-01 | ITRM | Option Ex | 3,487 | .00 | 0 |
| 2023-07-01 | ITRM | Option Ex | 1,779 | .00 | 0 |
| 2023-06-15 | ITRM | Option Ex | 15,853 | .00 | 0 |
| 2023-04-01 | ITRM | Option Ex | 1,299 | .00 | 0 |
| 2023-01-01 | ITRM | Option Ex | 761 | .00 | 0 |
| 2022-06-23 | ITRM | Option Ex | 36,798 | .00 | 0 |
| 2022-03-25 | ITRM | Option Ex | 10,494 | .00 | 0 |
| 2021-01-26 | ITRM | Sale | 33,143 | 1.73 | 57,337 |
| 2020-10-27 | ITRM | Buy | 61,540 | .00 | 0 |
| 2018-09-04 | ITRM | Buy | 500 | 10.00 | 5,000 |
| 2018-08-24 | ITRM | Buy | 500 | 10.00 | 5,000 |
| 2018-08-27 | ITRM | Buy | 500 | 10.00 | 5,000 |
| 2018-05-30 | ITRM | Buy | 2,000 | 13.00 | 26,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dunne Michael W. (Officer of Iterum Therapeutics Plc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.